2,3-dimethylphenylhydrazine | 84401-19-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 2,3-dimethylphenylhydrazine
• 英文别名: (2,3-Dimethylphenyl)hydrazine
• CAS: 84401-19-4
• 化学式: C₈H₁₂N₂
• mdl: MFCD02656651
• 分子量: 136.197
• InChiKey: PIBBBGRPSHLONB-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.9
• 重原子数：
  10
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  38
• 氢给体数：
  2
• 氢受体数：
  2

安全信息

• 危险等级：
  IRRITANT

反应信息

• 作为反应物：
  描述：

  2,3-dimethylphenylhydrazine 在 sodium hydride 作用下， 以 1,4-二氧六环 、 乙醇 为溶剂， 反应 6.0h， 生成 5-Chloro-2-(2,3-dimethylphenyl)-4-(4-methoxyphenoxy)pyridazin-3-one
  参考文献：
  名称：

  Design, synthesis and SAR analysis of novel potent and selective small molecule antagonists of NPBWR1 (GPR7)

  摘要：

  Novel smallmolecule antagonists ofNPBWR1 (GPR7) are herein reported. A high-throughput screening (HTS) of the Molecular Libraries-Small Molecule Repository library identified 5-chloro-4-(4-methoxyphenoxy)-2-(p-tolyl)pyridazin-3(2H)-one as a NPBWR1 hit antagonist with micromolar activity. Design, synthesis and structure-activity relationships study of the HTS-derived hit led to the identification of 5-chloro-2-(3,5-dimethylphenyl)-4-(4-methoxyphenoxy) pyridazin-3(2H)-one lead molecule with sub-micromolar antagonist activity at the target receptor and high selectivity against a panel of therapeutically relevant off-target proteins. This lead molecule may provide a pharmacological tool to clarify the molecular basis of the in vivo physiological function and therapeutic utility of NPBWR1 in diverse disease areas including inflammatory pain and eating disorders. (C) 2012 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2012.09.074
• 作为产物：
  描述：

  2,3-二甲基苯胺 生成 2,3-dimethylphenylhydrazine
  参考文献：
  名称：

  Franzen; Onsager; Faerden, Journal fur praktische Chemie (Leipzig 1954), 1918, vol. <2> 97, p. 344

  摘要：

  DOI：

文献信息

• New pyrazolones as 11b-HSD1 inhibitors for diabetes
  申请人：Amrein Kurt

  公开号：US20070049574A1

  公开（公告）日：2007-03-01

  Compounds of formula as well as pharmaceutically acceptable salts and esters thereof, wherein R 1 to R 4 have the significance given in claim 1 can be used in the form of pharmaceutical compositions.

  公式化合物以及医药可接受的它们的盐和酯，其中R1至R4的意义如权利要求1中所给出，可以用作药物组合物。
• Pyrazolones as inhibitors of 11B-hydroxysteroid dehydrogenase
  申请人：Banner Lester Bruce

  公开号：US20070049632A1

  公开（公告）日：2007-03-01

  Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of diseases such as, for example, type II diabetes mellitus and metabolic syndrome.

  本文提供了以下式(I)的化合物： 以及其药学上可接受的盐，其中取代基如规范中所披露的那样。这些化合物及含有它们的药物组合物对于治疗诸如II型糖尿病和代谢综合征等疾病是有用的。
• On the application of the extended Fujita–Nishioka equation to polysubstituted systems. A kinetic study of the rearrangement of several poly-substituted Z-arylhydrazones of 3-benzoyl-5-phenyl-1,2,4-oxadiazole into 2-aryl-4-benzoylamino-5-phenyl-1,2,3-triazoles in dioxane/water
  作者：Francesca D'Anna、Fiammetta Ferroni、Vincenzo Frenna、Susanna Guernelli、Camilla Zaira Lanza、Gabriella Macaluso、Vitalba Pace、Giovanni Petrillo、Domenico Spinelli、Raffaella Spisani

  DOI：10.1016/j.tet.2004.10.054

  日期：2005.1

  or penta-substituted Z-arylhydrazones of 3-benzoyl-5-phenyl-1,2,4-oxadiazole (1a–18a) into the relevant 2-aryl-4-benzoylamino-5-phenyl-1,2,3-triazoles (1b–18b) have been determined in 1:1 (v:v) dioxane/water in a wide range of pS+ (3.80–12.50) at different temperatures. The kinetic data obtained have been correlated with those previously collected for the rearrangement of ortho-, meta- and para-substituted

  3-苯甲酰基-5-苯基-1，2，4-恶二唑（1a – 18a）的几个二，三，四或五取代的Z-芳基hydr重排成相关的2-芳基-4-的重排率苯甲酰氨基-5-苯基-1,2,3-三唑（1b – 18b）已在不同温度下在1：1 p（v：v）二恶烷/水中以较大的p S +（3.80–12.50）测定。获得的动力学数据已与先前收集的用于重排邻，间和对位取代的Z-芳基azo（19a – 38a）的数据相关。）通过藤田和西冈提出，从而在考虑空间位线性自由能关系（LFER）的延伸的装置（Ë小号）和场（˚F ø在除了正常的电子效应）邻近效应（σ邻，间， p）。良好的相关系数被计算出（- [R ≥0.999），具有易感性常数（ρ，δ和˚F）接近先前对所获得的那些19A - 38A，当仅不包括数据的2,6-双-邻-取代的ž -arylhydrazones 11a和16 –图18a显示了比可预见的高得多的反应性，证
• [EN] PYRIDAZINONE DERIVATIVES<br/>[FR] DÉRIVÉS DE PYRIDAZINONE
  申请人：HOFFMANN LA ROCHE

  公开号：WO2010063610A1

  公开（公告）日：2010-06-10

  The present invention is concerned with novel pyridazinone derivatives of formula (I) wherein R1, R2, R3 and R4 are as defined in the description and in the claims, as well as physiologically acceptable salts and esters thereof. These compounds inhibit PDE10A and can be used as medicaments.

  本发明涉及一种新颖的吡啶并嗪酮衍生物，其化学式为（I），其中R1、R2、R3和R4如描述和权利要求中所定义，并且其生理上可接受的盐和酯。这些化合物抑制PDE10A，可用作药物。
• Agent for dyeing fibers comprising an indoline/indolium derivative
  申请人：——

  公开号：US20030079301A1

  公开（公告）日：2003-05-01

  The object of the present invention is an agent for dyeing fibers obtained by mixing two components and characterized in that one component (component A2) contains at least one carbonyl compound and the other component (component A1) contains at least one indoline derivative of formula (I) or a 3H-indoline derivative of formula (Ia) 1 as well as a multicomponent kit for dyeing and later decolorizing fibers, said kit containing both an agent according to the invention for producing a coloration on the fiber and an agent for the reductive removal of said coloration.

  本发明的对象是一种通过混合两种组分获得的染色纤维的染色剂，其特征在于一个组分（组分A2）含有至少一种羰基化合物，另一个组分（组分A1）含有至少一种式（I）的吲哚衍生物或式（Ia）的3H-吲哚衍生物，以及一种用于染色和后期脱色纤维的多组分套件，该套件包含根据本发明用于在纤维上产生着色的染色剂以及用于还原去除所述着色的染色剂。